Related references
Note: Only part of the references are listed.Role of Mitochondria in Ferroptosis
Minghui Gao et al.
MOLECULAR CELL (2019)
Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model
Yan Zhang et al.
CELL CHEMICAL BIOLOGY (2019)
To eat or not to eat - the metabolic flavor of ferroptosis
Minghui Gao et al.
CURRENT OPINION IN CELL BIOLOGY (2018)
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Yilei Zhang et al.
NATURE CELL BIOLOGY (2018)
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Jutija Hmeljaki et al.
CANCER DISCOVERY (2018)
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll et al.
NATURE CHEMICAL BIOLOGY (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan et al.
NATURE (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
Matthew Jennis et al.
GENES & DEVELOPMENT (2016)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
Glutaminolysis and Transferrin Regulate Ferroptosis
Minghui Gao et al.
MOLECULAR CELL (2015)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DcAF1-Mediated Inhibition of the Hippo Pathway Kinases Latsl and 2 in the Nucleus
Wei Li et al.
CANCER CELL (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Scott J. Dixon et al.
ELIFE (2014)
Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy
Sophie Papa et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus
Wei Li et al.
EMBO REPORTS (2012)
Coordinating developmental signaling: novel roles for the Hippo pathway
Xaralabos Varelas et al.
TRENDS IN CELL BIOLOGY (2012)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components
Nam-Gyun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
A Phase II Study of Sorafenib in Malignant Mesothelioma Results of Cancer and Leukemia Group B 30307
Sarita Dubey et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Absence of Glutathione Peroxidase 4 Affects Tumor Angiogenesis through Increased 12/15-Lipoxygenase Activity
Manuela Schneider et al.
NEOPLASIA (2010)
Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-Mediated cell death
Alexander Seiler et al.
CELL METABOLISM (2008)
The cell-cell adhesion molecule E-cadherin
F. van Roy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
The Hippo-YAP pathway: new connections between regulation of organ size and cancer
Bin Zhao et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane
T Okada et al.
JOURNAL OF CELL BIOLOGY (2005)
Share Paper
